Abstract
Objective: To review and discuss the mental health needs of children and adolescents in India.
Methods: Recent community-based and clinic-based epidemiological data in child and adolescent psychiatry (CAP) from a tertiary referral center for CAP in India [National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India] are reviewed. Results: The ICD-10 DCR criteria for CAP disorders and Rutter’s penta-axial diagnosis are used in these data. The community prevalence rate for CAP disorders is found to be 12.5% (n = 2064). The most common diagnoses in community are non-organic enuresis (6.2%), specific phobia (2.9%), ADHD (1.6%), stuttering (1.5%) and ODD (0.9%). Only 37.5 per cent of the families perceived that their children had any problem. The profile of CAP disorders among patients presenting to the CAP clinic [n=374 over six months period; age-group 0-16 years; 240 (64%) boys and 134 (36%) girls] differs from that in community: ADHD—16.6% (highest prevalence), autism spectrum disorders—15.5%, depression—12%, dissociative disorders—8.8%, bipolar disorder—4.2% and psychoses—4%. 284 (75%) of children evaluated in the clinic have at least one abnormal psychosocial situation. Physical abuse and the presence of parental psychopathology are significantly associated with psychiatric morbidity. Conclusions: Prevalence rates of CAP morbidity in India are lower than Western figures. With our total population figures, the absolute numbers with psychiatric morbidity would be very large. We discuss the implications for manpower training, practice, awareness building and policy initiatives.Keywords: Child and adolescent mental health, mental health in India, prevalence
Adolescent Psychiatry
Title:Global Child and Adolescent Mental Health Needs: Perspectives from a National Tertiary Referral Center in India
Volume: 3 Issue: 1
Author(s): Tejas S. Golhar and Shoba Srinath
Affiliation:
Keywords: Child and adolescent mental health, mental health in India, prevalence
Abstract: Objective: To review and discuss the mental health needs of children and adolescents in India.
Methods: Recent community-based and clinic-based epidemiological data in child and adolescent psychiatry (CAP) from a tertiary referral center for CAP in India [National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India] are reviewed. Results: The ICD-10 DCR criteria for CAP disorders and Rutter’s penta-axial diagnosis are used in these data. The community prevalence rate for CAP disorders is found to be 12.5% (n = 2064). The most common diagnoses in community are non-organic enuresis (6.2%), specific phobia (2.9%), ADHD (1.6%), stuttering (1.5%) and ODD (0.9%). Only 37.5 per cent of the families perceived that their children had any problem. The profile of CAP disorders among patients presenting to the CAP clinic [n=374 over six months period; age-group 0-16 years; 240 (64%) boys and 134 (36%) girls] differs from that in community: ADHD—16.6% (highest prevalence), autism spectrum disorders—15.5%, depression—12%, dissociative disorders—8.8%, bipolar disorder—4.2% and psychoses—4%. 284 (75%) of children evaluated in the clinic have at least one abnormal psychosocial situation. Physical abuse and the presence of parental psychopathology are significantly associated with psychiatric morbidity. Conclusions: Prevalence rates of CAP morbidity in India are lower than Western figures. With our total population figures, the absolute numbers with psychiatric morbidity would be very large. We discuss the implications for manpower training, practice, awareness building and policy initiatives.Export Options
About this article
Cite this article as:
S. Golhar Tejas and Srinath Shoba, Global Child and Adolescent Mental Health Needs: Perspectives from a National Tertiary Referral Center in India, Adolescent Psychiatry 2013; 3 (1) . https://dx.doi.org/10.2174/2210676611303010014
DOI https://dx.doi.org/10.2174/2210676611303010014 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
Current Alzheimer Research Translating Enzymology into Metabolic Regulation: The Case of the 2- Oxoglutarate Dehydrogenase Multienzyme Complex
Current Chemical Biology Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases
CNS & Neurological Disorders - Drug Targets Efficacy and Adverse Effects of Venlafaxine in Children and Adolescents with ADHD: A Systematic Review of Non-controlled and Controlled Trials
Reviews on Recent Clinical Trials Zolpidem Therapy for Movement Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Davunetide: Peptide Therapeutic in Neurological Disorders
Current Medicinal Chemistry Postnatal Brain Development and Psychotropic Drugs. Effects on Animals and Animal Models of Depression and Attention-Deficit/Hyperactivity Disorder
Current Pharmaceutical Design Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design The Interface Between Alzheimers Disease, Normal Aging, and Related Disorders
Current Aging Science Tau in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
Current Neuropharmacology Proteomic Alterations by Mutations Involved in Parkinson's Disease and Related Disorders
Current Protein & Peptide Science A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry The Overlapping Syndromes of the Pick Complex
Current Alzheimer Research Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
Current Alzheimer Research Reconstructing the Hsp90/Tau Machine
Current Enzyme Inhibition Translational Multimodality Neuroimaging
Current Drug Targets